Dr. Reddys Laboratories Ltd.

Dr Reddy's Laboratories has recalled 58,656 bottles of the heartburn drug lansoprazole in the United States due to a microbial contamination. It was classified as a ‘Class II’ recall which indicates a remote chance of severe adverse consequences or death due to the product flaw.

Dr. Reddy’s is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.